Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kinentia Biosciences provides contract research and manufacturing services across the drug discovery and development spectrum using its proprietary Deep Data Mining platform. It supports clients from early discovery through commercialization with GLP and c-GMP facilities in the US. The company is currently involved in exclusive US manufacturing of TC220, a novel boronated amino acid analog for BNCT cancer therapy that has shown improved tumor targeting over conventional agents in preclinical studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kinentia Biosciences.